Statements (51)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:fungus
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:amphotericin_B
gptkb:Clotrimazole |
gptkbp:caused_by |
candidiasis
invasive candidiasis thrush vaginal yeast infections |
https://www.w3.org/2000/01/rdf-schema#label |
Candida species
|
gptkbp:is_a |
gptkb:fungus
|
gptkbp:is_associated_with |
gptkb:Company
antibiotic use immunocompromised patients |
gptkbp:is_found_in |
vagina
gut oral cavity human microbiota |
gptkbp:is_linked_to |
hospital-acquired infections
mortality in severe cases |
gptkbp:is_often_depicted_as |
hospital settings
immunocompromised individuals neonates patients receiving broad-spectrum antibiotics patients with central venous catheters |
gptkbp:is_part_of |
fungal infections
infectious diseases clinical microbiology opportunistic infections normal flora fungal taxonomy mycotic diseases |
gptkbp:is_recognized_by |
gptkb:Research_Institute
molecular techniques culture methods |
gptkbp:is_studied_in |
mycology
epidemiology biofilm formation virulence factors diagnostic methods treatment strategies antifungal resistance |
gptkbp:is_vulnerable_to |
certain antifungals
|
gptkbp:social_responsibility |
gptkb:Person
blood tests biopsy |
gptkbp:treatment |
gptkb:posaconazole
gptkb:amphotericin_B gptkb:fluconazole antifungal medications echinocandins voriconazole |